CELZ Creative Medical Technology Hol
$0.70▼ -1.69%
Healthcare
Other
Volume 32.4K
Avg Volume (10D) 112.3K
Key Metrics & Fundamentals
Market Cap
$5.31M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.62 - 6.25
% vs 50 MA
-26.39%
% vs 200 MA
-55.59%
RSI-14
34.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.77
Free Cash Flow
-$1.47M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.54M
COGS
$0
Operating Exp
$1.56M
Operating Income
-$1.56M
EBIT
-$1.56M
Pretax Income
-$1.51M
Net Income
-$1.51M
EPS (Diluted)
-0.41
Price & Volume History
Loading chart…
Recent News
Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
GlobeNewswire · Oct 20, 2026 9:15 AM ET
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
GlobeNewswire · Sep 17, 2026 9:00 AM ET
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
GlobeNewswire · Aug 20, 2026 9:15 AM ET
Creative Medical Receives U.S. Patent Allowance for Exosome-Based Type 1 Diabetes Immunotherapy
InvestorsHub · Aug 6, 2026 11:04 AM ET
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
GlobeNewswire · Aug 6, 2026 9:15 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See CELZ's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.